SEC 13F Intelligence

Bristol John W & Co Inc /Ny/ / TMO

Bristol John W & Co Inc /Ny/’s Thermo Fisher Scientific Inc Position

Does Bristol John W & Co Inc /Ny/ own Thermo Fisher Scientific Inc (TMO)? Yes342.8K shares worth $168M (+2.77% of its 13F portfolio) as of Q1 2026, down from 347.0K shares the prior filed quarter.

Position Value
$168M
Q1 2026
Shares
342.8K
% of Portfolio
+2.77%
Quarters Held
30
currently held

Position History TMO

Reported value by quarter
Q4 ’18: $73MQ4 ’18Q1 ’19: $89MQ2 ’19: $94MQ3 ’19: $96MQ4 ’19: $105MQ4 ’19Q1 ’20: $111MQ2 ’20: $139MQ3 ’20: $169MQ4 ’20: $153MQ4 ’20Q1 ’21: $150MQ2 ’21: $164MQ3 ’21: $183MQ4 ’21: $212MQ4 ’21Q1 ’22: $184MQ2 ’22: $165MQ3 ’22: $154MQ4 ’22: $167MQ4 ’22Q1 ’23: $176MQ2 ’23: $169MQ3 ’23: $163MQ4 ’23: $162MQ4 ’23Q1 ’24: $178MQ2 ’24: $165MQ3 ’24: $183MQ4 ’24: $150MQ4 ’24Q1 ’25: $141MQ2 ’25: $146MQ3 ’25: $172MQ4 ’25: $201MQ4 ’25Q1 ’26: $168Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026342.8K$168M+2.77%
Q4 2025347.0K$201M+3.09%
Q3 2025353.9K$172M+2.71%
Q2 2025360.4K$146M+2.37%
Q1 2025282.6K$141M+2.40%
Q4 2024288.6K$150M+2.47%
Q3 2024295.1K$183M+2.91%
Q2 2024298.8K$165M+2.68%
Q1 2024305.6K$178M+3.02%
Q4 2023306.0K$162M+2.99%
Q3 2023321.3K$163M+3.21%
Q2 2023324.1K$169M+3.20%
Q1 2023304.6K$176M+3.61%
Q4 2022304.2K$167M+3.98%
Q3 2022303.6K$154M+3.85%
Q2 2022303.1K$165M+4.03%
Q1 2022311.4K$184M+3.65%
Q4 2021317.4K$212M+3.66%
Q3 2021320.8K$183M+3.42%
Q2 2021325.6K$164M+3.02%
Q1 2021328.4K$150M+3.06%
Q4 2020329.2K$153M+3.16%
Q3 2020383.3K$169M+3.84%
Q2 2020382.9K$139M+3.44%
Q1 2020389.7K$111M+3.44%
Q4 2019324.4K$105M+2.54%
Q3 2019325.9K$96M+2.47%
Q2 2019320.1K$94M+2.48%
Q1 2019323.3K$89M+2.43%
Q4 2018326.6K$73M+2.34%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bristol John W & Co Inc /Ny/’s full portfolio or all institutional holders of TMO.